Delivery Order SPE2DB22D2206-SPE2DB24FJC02

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJC02
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA) to provide PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $56,671.51 and an ultimate completion date of July 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current delivery order is not designated as a set-aside contract.

Generated 10/7/24, 10:56 AM